Posted by Michael Wonder on 11 Jul 2018
Pfizer to roll back drug price hikes after Trump tweets
11 July 2018 - Pfizer Inc. said overnight that it would “defer” some recent drug-price increases, reversing course after US President Donald Trump criticised the company.
The New York-based drug maker, one of the world’s biggest pharmaceutical companies by sales, faced criticism from President Trump and others after raising the prices of more than 40 drugs last week.
Pfizer backtracked after chief executive Ian Read spoke with US President Trump and Health and Human Services Secretary Alex Azar.
